Two Sigma Advisers’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-11,500
Closed -$216K – 1426
2025
Q4
$216K Buy
+11,500
New +$174K ﹤0.01% 2099
2025
Q1
– Sell
-14,000
Closed -$247K – 2522
2024
Q4
$247K Buy
14,000
+3,600
+35% +$68.3K ﹤0.01% 2057
2024
Q3
$238K Sell
10,400
-18,300
-64% -$413K ﹤0.01% 2005
2024
Q2
$659K Buy
28,700
+15,200
+113% +$469K ﹤0.01% 1772
2024
Q1
$535K Sell
13,500
-14,200
-51% -$562K ﹤0.01% 1845
2023
Q4
$1.1M Buy
+27,700
New +$1.16M ﹤0.01% 1607

Other funds holding NRC

Two Sigma Advisers's NRC Position: Q1 2026 in Review

Two Sigma Advisers sold out of NRC Health Common Stock (NRC) in Q1 2026, closing a stake of 11,500 shares — an estimated $216K sold.

Two Sigma Advisers first reported a position in NRC in Q4 2023 and held it in 6 quarters. The position peaked at $1.1M in Q4 2023. 121 funds tracked by Wall St. Rank hold NRC as of Q1 2026.

  • Two Sigma Advisers reported no remaining NRC Health Common Stock position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 11,500 NRC Health Common Stock shares in Q1 2026, an estimated $216K.
  • Two Sigma Advisers first reported a position in NRC Health Common Stock in Q4 2023 and held it in 6 quarters.
  • Two Sigma Advisers's NRC Health Common Stock position peaked at $1.1M in Q4 2023.
  • 121 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.